4th Annual Genome Editing US Congress
FluidFM BOT BIO Series – Boost CRISPR efficiency by direct delivery into the nucleus.
During this digital congress, we will present our unique FluidFM BOT BIO Series, a highly automated solution coupled to a fully automated Olympus IX83 inverted microscope with fluorescence. With it, deliver your CRISPR-Cas complexes directly where they are required: the nucleus. This avoids the risk of degradation of the repair template in the cytoplasm, therefore increasing the chance of HDR. Whether you are working with hard-to-transfect cells like iPSCs or a standard cell line such as CHO cells, you can selectively choose the cells you want to inject within a cell culture without affecting the neighboring cells. In contrast to many conventional transfection methods, no toxic compounds are necessary to allow the complexes to enter the cell. The gentle injection process preserves cell viability over 95%.
FluidFM – GO BEYOND.
About the congress
The 4th Annual Genome Editing US Congress is part of the NextGen Omics Series US which provides a networking and discussion platform on delivering genomic medicine and personalized patient care using Next Generation Sequencing, Single Cell and Genomic Editing technologies.
With gene editing tools becoming advanced enough to realize therapeutic potential, decision-makers working in academia and pharma are looking to consolidate their techniques to facilitate disease modelling, drug development and clinical studies. Meet over 350 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
Meet us online
Participating from Cytosurge:
Alexander Serre, VP Cell + Bioscience BU
Dr. Paul Monnier, Field Application Scientist
"FluidFM: A new approach to CRISPR gene editing" by Dr. Paul Monnier, Field Application Scientist
April 7, 12:20-12:50
Stream 4: Genome editing technologies & techniques
For more information on the event, please go to the website of the 4th Annual Genome Editing US Congress.